The foundations
of pharmaceutical biotechnology mainly lie in the capability of plants,
microorganism and animals to produce low and high molecular weight compounds
useful as therapeutics.
Although
molecules from plants and microorganisms are preferred extraction from plant biomass
needs tedious downstream processing while in case of microorganisms it is easy
with fewer amounts of impurities.
Pharmaceutical
biotechnology is poised to flourish for the last 4-6 decades with the advent of
recombinant DNA technology and metabolic engineering supported by the
well-developed bioprocess technology. Large scale production and cost
effectiveness and affordability could be achieved by way of synergising all
these technologies.
No comments:
Post a Comment